A PYMNTS Company

US: Judge cancels trial for 14 year old CME derivatives antitrust lawsuit

By  |  May 7, 2018

According to public court documents, US Judge Thomas Durkin has cancelled a planned trial into the practices of CME Group, parent to the Chicago Mercantile Exchange and other companies, defending its home turf against rivals. This decision casts a 14 year old antitrust lawsuit into limbo.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The lawsuit, brought by Eurex, the derivatives arm of Deutsche Börse, alleged that the world’s largest futures exchange undermined Eurex’s plan to wrest CME and the Chicago Board of Trade’s market share of prized contracts like Treasury bond futures, via a venue called US Futures Exchange.

    The parties now have to wait for the court’s written opinion on the pending motions for a summary judgment, the document said. The opinion could come in a month’s time.

    Full Content: Financial Times

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.